Copyright Reports & Markets. All rights reserved.

Global Vaccines For Children (VFC) Market Research Report 2021

Request for Sample of this report
Buy now

1 Vaccines For Children (VFC) Market Overview

  • 1.1 Product Overview and Scope of Vaccines For Children (VFC)
  • 1.2 Vaccines For Children (VFC) Segment by Type
    • 1.2.1 Global Vaccines For Children (VFC) Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Recombinant Vaccines
    • 1.2.3 Viral Vaccines
    • 1.2.4 Polysaccharide Vaccines
    • 1.2.5 Others
  • 1.3 Vaccines For Children (VFC) Segment by Application
    • 1.3.1 Global Vaccines For Children (VFC) Sales Comparison by Application: (2021-2027)
    • 1.3.2 Government Institution
    • 1.3.3 Private Sector
    • 1.3.4 Other
  • 1.4 Global Vaccines For Children (VFC) Market Size Estimates and Forecasts
    • 1.4.1 Global Vaccines For Children (VFC) Revenue 2016-2027
    • 1.4.2 Global Vaccines For Children (VFC) Sales 2016-2027
    • 1.4.3 Vaccines For Children (VFC) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Vaccines For Children (VFC) Market Competition by Manufacturers

  • 2.1 Global Vaccines For Children (VFC) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Vaccines For Children (VFC) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Vaccines For Children (VFC) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Vaccines For Children (VFC) Manufacturing Sites, Area Served, Product Type
  • 2.5 Vaccines For Children (VFC) Market Competitive Situation and Trends
    • 2.5.1 Vaccines For Children (VFC) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Vaccines For Children (VFC) Players Market Share by Revenue
    • 2.5.3 Global Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Vaccines For Children (VFC) Retrospective Market Scenario by Region

  • 3.1 Global Vaccines For Children (VFC) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Vaccines For Children (VFC) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Vaccines For Children (VFC) Market Facts & Figures by Country
    • 3.3.1 North America Vaccines For Children (VFC) Sales by Country
    • 3.3.2 North America Vaccines For Children (VFC) Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Vaccines For Children (VFC) Market Facts & Figures by Country
    • 3.4.1 Europe Vaccines For Children (VFC) Sales by Country
    • 3.4.2 Europe Vaccines For Children (VFC) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Vaccines For Children (VFC) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Vaccines For Children (VFC) Sales by Region
    • 3.5.2 Asia Pacific Vaccines For Children (VFC) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Vaccines For Children (VFC) Market Facts & Figures by Country
    • 3.6.1 Latin America Vaccines For Children (VFC) Sales by Country
    • 3.6.2 Latin America Vaccines For Children (VFC) Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Vaccines For Children (VFC) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Vaccines For Children (VFC) Sales by Country
    • 3.7.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Vaccines For Children (VFC) Historic Market Analysis by Type

  • 4.1 Global Vaccines For Children (VFC) Sales Market Share by Type (2016-2021)
  • 4.2 Global Vaccines For Children (VFC) Revenue Market Share by Type (2016-2021)
  • 4.3 Global Vaccines For Children (VFC) Price by Type (2016-2021)

5 Global Vaccines For Children (VFC) Historic Market Analysis by Application

  • 5.1 Global Vaccines For Children (VFC) Sales Market Share by Application (2016-2021)
  • 5.2 Global Vaccines For Children (VFC) Revenue Market Share by Application (2016-2021)
  • 5.3 Global Vaccines For Children (VFC) Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 GSK
    • 6.1.1 GSK Corporation Information
    • 6.1.2 GSK Description and Business Overview
    • 6.1.3 GSK Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 GSK Vaccines For Children (VFC) Product Portfolio
    • 6.1.5 GSK Recent Developments/Updates
  • 6.2 Sanofi
    • 6.2.1 Sanofi Corporation Information
    • 6.2.2 Sanofi Description and Business Overview
    • 6.2.3 Sanofi Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanofi Vaccines For Children (VFC) Product Portfolio
    • 6.2.5 Sanofi Recent Developments/Updates
  • 6.3 Merck
    • 6.3.1 Merck Corporation Information
    • 6.3.2 Merck Description and Business Overview
    • 6.3.3 Merck Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Merck Vaccines For Children (VFC) Product Portfolio
    • 6.3.5 Merck Recent Developments/Updates
  • 6.4 Pfizer
    • 6.4.1 Pfizer Corporation Information
    • 6.4.2 Pfizer Description and Business Overview
    • 6.4.3 Pfizer Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Pfizer Vaccines For Children (VFC) Product Portfolio
    • 6.4.5 Pfizer Recent Developments/Updates
  • 6.5 Jintan
    • 6.5.1 Jintan Corporation Information
    • 6.5.2 Jintan Description and Business Overview
    • 6.5.3 Jintan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Jintan Vaccines For Children (VFC) Product Portfolio
    • 6.5.5 Jintan Recent Developments/Updates
  • 6.6 CSL
    • 6.6.1 CSL Corporation Information
    • 6.6.2 CSL Description and Business Overview
    • 6.6.3 CSL Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 CSL Vaccines For Children (VFC) Product Portfolio
    • 6.6.5 CSL Recent Developments/Updates
  • 6.7 MedImmune LLC
    • 6.6.1 MedImmune LLC Corporation Information
    • 6.6.2 MedImmune LLC Description and Business Overview
    • 6.6.3 MedImmune LLC Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 MedImmune LLC Vaccines For Children (VFC) Product Portfolio
    • 6.7.5 MedImmune LLC Recent Developments/Updates
  • 6.8 J&J(Crucell)
    • 6.8.1 J&J(Crucell) Corporation Information
    • 6.8.2 J&J(Crucell) Description and Business Overview
    • 6.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 J&J(Crucell) Vaccines For Children (VFC) Product Portfolio
    • 6.8.5 J&J(Crucell) Recent Developments/Updates
  • 6.9 China National Biotec
    • 6.9.1 China National Biotec Corporation Information
    • 6.9.2 China National Biotec Description and Business Overview
    • 6.9.3 China National Biotec Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 China National Biotec Vaccines For Children (VFC) Product Portfolio
    • 6.9.5 China National Biotec Recent Developments/Updates
  • 6.10 Tiantan
    • 6.10.1 Tiantan Corporation Information
    • 6.10.2 Tiantan Description and Business Overview
    • 6.10.3 Tiantan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Tiantan Vaccines For Children (VFC) Product Portfolio
    • 6.10.5 Tiantan Recent Developments/Updates
  • 6.11 Hualan
    • 6.11.1 Hualan Corporation Information
    • 6.11.2 Hualan Vaccines For Children (VFC) Description and Business Overview
    • 6.11.3 Hualan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Hualan Vaccines For Children (VFC) Product Portfolio
    • 6.11.5 Hualan Recent Developments/Updates
  • 6.12 Kangtai
    • 6.12.1 Kangtai Corporation Information
    • 6.12.2 Kangtai Vaccines For Children (VFC) Description and Business Overview
    • 6.12.3 Kangtai Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Kangtai Vaccines For Children (VFC) Product Portfolio
    • 6.12.5 Kangtai Recent Developments/Updates
  • 6.13 Hissen
    • 6.13.1 Hissen Corporation Information
    • 6.13.2 Hissen Vaccines For Children (VFC) Description and Business Overview
    • 6.13.3 Hissen Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Hissen Vaccines For Children (VFC) Product Portfolio
    • 6.13.5 Hissen Recent Developments/Updates

7 Vaccines For Children (VFC) Manufacturing Cost Analysis

  • 7.1 Vaccines For Children (VFC) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Vaccines For Children (VFC)
  • 7.4 Vaccines For Children (VFC) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Vaccines For Children (VFC) Distributors List
  • 8.3 Vaccines For Children (VFC) Customers

9 Vaccines For Children (VFC) Market Dynamics

  • 9.1 Vaccines For Children (VFC) Industry Trends
  • 9.2 Vaccines For Children (VFC) Growth Drivers
  • 9.3 Vaccines For Children (VFC) Market Challenges
  • 9.4 Vaccines For Children (VFC) Market Restraints

10 Global Market Forecast

  • 10.1 Vaccines For Children (VFC) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Vaccines For Children (VFC) by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Vaccines For Children (VFC) by Type (2022-2027)
  • 10.2 Vaccines For Children (VFC) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Vaccines For Children (VFC) by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Vaccines For Children (VFC) by Application (2022-2027)
  • 10.3 Vaccines For Children (VFC) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Vaccines For Children (VFC) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Vaccines For Children (VFC) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Recombinant Vaccines
    Viral Vaccines
    Polysaccharide Vaccines
    Others

    Segment by Application
    Government Institution
    Private Sector
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    GSK
    Sanofi
    Merck
    Pfizer
    Jintan
    CSL
    MedImmune LLC
    J&J(Crucell)
    China National Biotec
    Tiantan
    Hualan
    Kangtai
    Hissen

    Buy now